Written in a very partisan way, although the description of how stock buy backs create bad incentives for CEOs sounds convincing to me.

Nevertheless, I can't help but think that you are seeing this issue to negatively.

"The point of the article is that AI as a research tool is insufficient to result in improvements to patient outcomes on its own." This seems unlikely if you consider this question as-is. Past technological improvements has made healthcare better overall without requiring societal changes necessarily. Take mRNA vaccines, a technology that has improved Covid-19 outcomes tremendously. Sure, certain groups have less access than other groups, but surely even marginalized groups are better off overall because of the existence of these vaccines. Health is not a zero-sum game.

And I think this negative attitude also misses the potential of AI by default. Yeah it sucks that not everyone gets MRI access, but those that do will benefit, including marginalized groups. I guess it feels wrong to some people to express a positive sentiment at an unjust state of affairs, but improved diagnosis and treatments translate into lives saved.

You also have to compare AI to the status quo. Sure, AI will have biases, but so do humans (as Rachel points out!) and the decisive question is whether AI has less biases (similarly to how safety of self driving cars is judged). With AI you at least have a chance of analyzing the decision making, and making it objective. We should be extremely excited about this possibility!